Semaglutide
From $299/mo with medication included, and every GLP-1 ships the same day.
Check my BMI eligibilityA licensed clinician reviews your health history before anything is prescribed.
Start a free consultationCellular support
ApoB, Lp(a), hs-CRP and more, reviewed by a licensed clinician.
Start with a free consultation$199 for 3 or more pets. You only pay if the clinician approves your letter.
Get your ESA letter$229 for 3 dogs. For housing and travel with a trained psychiatric service dog.
Get your PSD letterLabs & testing
Hair, skin & wellness
Mobile IV therapyRetatrutide is the brand name for retatrutide, approved for investigational triple agonist therapy. HealifyNow evaluates, prescribes when appropriate, and monitors throughout. Real medicine, real follow-up.
Retatrutide contains the active ingredient retatrutide, approved by the FDA for investigational triple agonist therapy. HealifyNow prescribes after appropriate clinical evaluation, with comprehensive labs and ongoing monitoring. The active molecule is the same as compounded retatrutide prepared by licensed compounding pharmacies — we offer both options based on your situation, insurance coverage, and clinical fit.
The class of medication and its mechanism is well-understood. The evidence for efficacy and safety is robust. The clinical protocol is straightforward when done with proper oversight: comprehensive baseline labs, careful dose titration, regular follow-up, lab and weight monitoring during treatment, and adjustments based on response and tolerance.
HealifyNow does this work through telehealth — comprehensive video visits with licensed U.S. clinicians, lab orders to Quest or LabCorp near you, prescriptions filled by licensed pharmacies that ship discreetly to your door, and ongoing communication with your care team through our HIPAA-compliant platform.
You meet the medical criteria for Retatrutide as evaluated by your clinician.
Standard baseline labs are part of the program.
Personal and family medical history reviewed thoroughly.
Your clinician sets honest expectations about what the medication can and can't do.
From your first message to your medication arriving at your door — clinician-guided, every step.
A care team member meets with you to understand your goals, medical history, and treatment preferences. The first visit is no-cost and no-commitment — we want you to be confident before moving forward.
Connect by secure video or phone with a U.S.-licensed physician or nurse practitioner who reviews your full picture — labs, prior treatments, current medications, and lifestyle — and decides what is clinically appropriate.
If your clinician determines treatment is right for you, they issue a prescription that goes to a licensed U.S. pharmacy. We coordinate discreet shipping, or you can fill it locally. Follow-up visits are built in.
Retatrutide is an investigational medication that activates three hormone receptors: GIP, GLP-1 and glucagon. The GLP-1 and GIP actions reduce appetite and improve blood sugar control, while glucagon receptor activity may increase energy use.
It's still being studied in clinical trials and isn't FDA-approved, so it can't be prescribed. FDA-approved GLP-1 options are available today.
Your clinician will review every relevant detail with you. Here are the most important points to know up front.
Retatrutide is still in clinical trials. No licensed clinician can prescribe it outside a study.
Products sold online as research peptides are unregulated and not made for human use. Their contents and dose can't be trusted.
Trial participants most often reported nausea, diarrhea and vomiting, similar to other GLP-1 medications.
Tirzepatide, semaglutide and Foundayo are FDA-approved options a clinician can prescribe today.
All medications must be prescribed by a licensed provider based on medical necessity. Treatment is not suitable for everyone. Results may vary.
The only safe way to take retatrutide today is through a clinical trial. You can search for enrolling studies on ClinicalTrials.gov.
If you want to start treatment now, a licensed clinician can evaluate you for an FDA-approved GLP-1 medication.
Get a fast read on whether this is worth a deeper conversation.
Patients served across the U.S.
Member satisfaction with care team
Average review rating
From visit to medication shipment
We built HealifyNow because telehealth done badly is everywhere — and telehealth done right still feels rare. Here is what makes us different.
No waiting rooms, no faxed forms, no insurance hoops. Quick consults, simple intake, prescriptions handled digitally.
Real physicians, nurse practitioners, and specialists with active licenses. Not chatbots, not offshore call centers.
Medications ship from licensed U.S. pharmacies in plain packaging. Most orders arrive in 2-5 business days.
Reach a real human seven days a week. Most messages get a clinical reply within a few hours, not days.
HealifyNow prescriptions are reviewed and authorized by independently licensed physicians — real doctors with real credentials from top medical institutions in the United States.
A board-certified physician who brings a rigorous, pharmacology-driven lens to longevity medicine and weight management.
A Columbia-trained physician and former collegiate athlete focused on metabolic function, body composition, and healthspan.
A board-certified OB-GYN and ACOG Fellow with more than four decades of experience in women's health.
Real people, real results. Names and details published with permission.
"Started Retatrutide at 248 lbs, BMI 38. Twelve months later: 197 lbs, BMI 30. Knee pain gone, off two blood pressure meds. The food noise quieted within three weeks and that alone was life-changing."
"Tried every diet for 20 years. Retatrutide is the first thing that actually worked. Down 41 lbs in 8 months. The hunger I'd been fighting since adolescence finally stopped."
"HealifyNow's process was simple. Labs, phone or video visit, prescription. Down 28 lbs in 5 months on Retatrutide. Felt supported the entire way."
HealifyNow makes it easy to move forward with confidence. Here are the answers to what people ask us most.
Retatrutide is the brand name for retatrutide, approved for investigational triple agonist therapy.
Effects develop over weeks. Visible changes typically by week 4-8 of treatment at therapeutic dose.
Insurance coverage varies. We help you check, and offer cash-pay pricing transparently. Compounded alternatives may be more affordable.
Your clinician is reachable through the platform. Most side effects can be managed with dose adjustments or supportive care.
Most weight-loss and metabolic medications require ongoing use to maintain effect. Discuss long-term plans with your clinician.
Your clinician will discuss the comparative profiles of medications appropriate for your situation.
Any Quest or LabCorp draw center. Over 5,000 locations nationwide.
Absolutely. We provide your records and lab results for ongoing coordination.
No. Retatrutide is not FDA-approved, so no licensed clinician can legally prescribe it outside a clinical trial. You can get evaluated online for FDA-approved alternatives.
No. Retatrutide is an investigational medication from Eli Lilly that is still in clinical trials, and there's no confirmed approval date.
In Eli Lilly's TRIUMPH-1 trial, people on the highest dose lost an average of about 28% of body weight over 80 weeks. Trial results don't guarantee individual outcomes.
No. Products sold online as research peptides are unregulated and not made for human use, so their purity and dose can't be trusted.
FDA-approved options include tirzepatide (Zepbound), semaglutide (Wegovy) and Foundayo, a daily GLP-1 pill. A clinician can help you choose.
Tirzepatide activates two receptors (GIP and GLP-1). Retatrutide adds a third, glucagon, which may increase energy use, but it's still being studied.
Search for retatrutide on ClinicalTrials.gov to see studies that are enrolling. Each trial has its own eligibility criteria.
Book a free consultation. Real evaluation, transparent pricing, clinical support.